Extended Spectrum β-lactamase and Carbapenemase EQA/PT Scheme

To assess the laboratories ability to detect β-lactamase and carbapenemase coding genes in a clinical setting using their routine molecular diagnostic procedures.

Total Number of Challenges: 1
Number of Panel Members: 8
Distribution / Testing Period: Q3
Sample NA Target Source Cultured and/or Clinical material
Genotypic Variant Various drug resistance strains
Matrix Panel Format Physiological Buffer
Panel Member Target Range Clinically relevant range of microorganisms for detection and determination
Panel Member Sample Volume 0.5 ml
Panel Sample Pre-treatment Requirement Ready for analysis. Treat as clinical samples and analyse accordingly.
Panel Analysis Type Molecular typing
Panel Testing Evaluated by various molecular methodologies
Storage / Shipment Conditions <-20°C / Frozen on Dry-ice
Accreditation / Regulatory Status Accredited to ISO 17043
SKU: QAB134162_1 Categories: , , Tags: ,

$1,149.49